a year ago
TNYA
AnalystsJoseph PantginisJoseph Pantginis's Stock Forecasts
AnalystsJoseph Pantginis
Analyst Ranking
Top 6%
#327 out of 5497 analysts
Average Return
+3.64%
Win Rate
41%416 out of 1016
Risk vs Reward
Poor
Good
Joseph Pantginis's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Celldex Therapeutics IncCLDX | +1,183.78% | $1.85 | $23.75 | 2020-03-27 - 2021-03-26 | Buy |
Cidara Therapeutics IncCDTX | +938.85% | $21.31 | $221.38 | 2025-06-18 - 2026-01-06 | Buy |
Alpine Immune Sciences IncALPN | +694.86% | $8.17 | $64.94 | 2023-05-12 - 2024-05-10 | Buy |
Biomea Fusion IncBMEA | +644.47% | $4.79 | $35.66 | 2022-06-02 - 2023-06-01 | Buy |
Capricor Therapeutics IncCAPR | +501.06% | $2.84 | $17.07 | 2023-10-04 - 2024-10-03 | Buy |
Joseph Pantginis Analyst Color
Get additional color on Joseph Pantginis's coverage of popular stocks
2 years ago
BLRX
2 years ago
CAPR
2 years ago
VKTX
Joseph Pantginis's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Omniab IncOABI | 8 | Buy | $11.00 | +154.04% | Reiterates | 5 days ago |
Rigel Pharmaceuticals IncRIGL | 27 | Buy | $85.00 | +85.23% | Maintains | 8 days ago |
Pds Biotechnology CorpPDSB | 33 | Buy | $7.00 | +3,111.01% | Maintains | 9 days ago |
Shattuck Labs IncSTTK | 22 | Buy | $14.00 | +85.92% | Maintains | 11 days ago |
Ligand Pharmaceuticals IncLGND | 25 | Buy | $358.00 | +25.05% | Maintains | 16 days ago |
Capricor Therapeutics IncCAPR | 30 | Hold | N/A | N/A | Downgrades | 23 days ago |
Q32 Bio IncQTTB | 3 | Buy | $36.00 | +125.42% | Maintains | 25 days ago |
Lineage Cell Therapeutics IncLCTX | 15 | Buy | $9.00 | +733.33% | Reiterates | a month ago |
Nuvectis Pharma IncNVCT | 11 | Buy | $39.00 | +65.53% | Maintains | 2 months ago |
Krystal Biotech IncKRYS | 38 | Buy | $361.00 | +4.16% | Maintains | 2 months ago |
Celldex Therapeutics IncCLDX | 36 | Buy | $42.00 | +4.01% | Reiterates | 2 months ago |
Anaptysbio IncANAB | 1 | Buy | $95.00 | +64.53% | Assumes | 2 months ago |
Biocardia IncBCDA | 17 | Buy | $25.00 | +2,375.25% | Reiterates | 2 months ago |
Fractyl Health IncGUTS | 5 | Buy | $8.00 | +925.64% | Reiterates | 3 months ago |
Travere Therapeutics IncTVTX | 9 | Buy | $67.00 | +1.96% | Maintains | 3 months ago |
Prokidney CorpPROK | 2 | Buy | $12.00 | +645.34% | Reiterates | 3 months ago |
Neuphoria Therapeutics IncNEUP | 10 | Hold | N/A | N/A | Downgrades | 3 months ago |
Lisata Therapeutics IncLSTA | 19 | Hold | N/A | N/A | Downgrades | 3 months ago |
Cytokinetics IncCYTK | 49 | Buy | $140.00 | +82.20% | Maintains | 3 months ago |
Clene IncCLNN | 30 | Buy | $31.00 | +617.59% | Reiterates | 4 months ago |
Esperion Therapeutics IncESPR | 31 | Hold | $3.16 | -0.63% | Downgrades | 4 months ago |
Xoma Royalty CorpXOMA | 27 | Hold | $39.00 | -2.91% | Downgrades | 4 months ago |
Compass Therapeutics IncCMPX | 19 | Buy | $24.00 | +900.00% | Reiterates | 4 months ago |
Adlai Nortye LtdANL | 6 | Buy | $20.00 | +45.99% | Maintains | 4 months ago |
Cadrenal Therapeutics IncCVKD | 6 | Buy | $13.00 | +707.45% | Maintains | 4 months ago |
Aprea Therapeutics IncAPRE | 17 | Buy | $1.20 | +87.50% | Maintains | 5 months ago |
Pharming Group NvPHAR | 18 | Buy | $37.00 | +212.24% | Reiterates | 5 months ago |
Lexicon Pharmaceuticals IncLXRX | 25 | Buy | $6.00 | +160.87% | Reiterates | 5 months ago |
Viking Therapeutics IncVKTX | 35 | Buy | $102.00 | +200.97% | Reiterates | 5 months ago |
Biomx IncPHGE | 18 | Hold | N/A | N/A | Downgrades | 5 months ago |
Fortress Biotech IncFBIO | 4 | Buy | $17.00 | +492.33% | Reiterates | 6 months ago |
Armata Pharmaceuticals IncARMP | 16 | Buy | $15.00 | +194.12% | Maintains | 6 months ago |
Calcimedica IncCALC | 13 | Hold | N/A | N/A | Downgrades | 7 months ago |
Tempest Therapeutics IncTPST | 20 | Buy | $11.00 | +957.69% | Upgrades | 7 months ago |
Kura Oncology IncKURA | 24 | Buy | $40.00 | +236.42% | Reiterates | 7 months ago |
Tenaya Therapeutics IncTNYA | 20 | Buy | $3.00 | +330.42% | Maintains | 8 months ago |
Iovance Biotherapeutics IncIOVA | 28 | Buy | $9.00 | +8.56% | Maintains | 10 months ago |
Newamsterdam Pharma Co NvNAMS | 1 | Buy | $52.00 | +86.58% | Assumes | 10 months ago |
Astria Therapeutics IncATXS | 25 | Hold | N/A | N/A | Downgrades | 10 months ago |
Atyr Pharma IncATYR | 24 | Hold | N/A | N/A | Downgrades | a year ago |
Faeth Therapeutics IncFTH | 1 | Buy | $30.00 | N/A | Maintains | a year ago |
Edgewise Therapeutics IncEWTX | 1 | Buy | $42.00 | N/A | Initiates Coverage On | a year ago |
Phio Pharmaceuticals CorpPHIO | 2 | Buy | $14.00 | N/A | Reiterates | a year ago |
Cidara Therapeutics IncCDTX | 2 | Buy | $53.00 | N/A | Maintains | a year ago |
Actinium Pharmaceuticals IncATNM | 30 | Buy | $4.00 | N/A | Reiterates | a year ago |
Moleculin Biotech IncMBRX | 2 | Buy | $100.00 | N/A | Reiterates | a year ago |
Galectin Therapeutics IncGALT | 1 | Buy | $6.00 | N/A | Assumes | a year ago |
Biolinerx LtdBLRX | 13 | Buy | $26.00 | N/A | Reiterates | a year ago |
Gri Bio IncGRI | 3 | Buy | $280.00 | N/A | Reiterates | a year ago |
Curis IncCRIS | 1 | Buy | $340.00 | N/A | Assumes | a year ago |
Kyntra Bio IncKYNB | 3 | Buy | $250.00 | N/A | Reiterates | a year ago |
Iterum Therapeutics PLCITRMF | 1 | Buy | $9.00 | N/A | Assumes | a year ago |
Biomea Fusion IncBMEA | 29 | Buy | $18.00 | N/A | Maintains | a year ago |
Yarrow Bioscience IncYARW | 20 | Buy | $225.00 | N/A | Maintains | a year ago |
Xenetic Biosciences IncXBIO | 9 | Hold | N/A | N/A | Reiterates | a year ago |
Kairos Pharma LtdKAPA | 1 | Buy | $12.00 | N/A | Initiates Coverage On | a year ago |
Aptose Biosciences IncAPTOF | 15 | Buy | $6.00 | N/A | Maintains | a year ago |
Checkpoint Therapeutics IncCKPT | 17 | Hold | $4.10 | N/A | Downgrades | a year ago |
Palatin Technologies IncPTN | 27 | Buy | $7.00 | N/A | Maintains | 2 years ago |
Genenta Science SpaGNTA | 4 | Buy | $25.00 | N/A | Reiterates | 2 years ago |
Panbela Therapeutics IncPBLA | 11 | Hold | N/A | N/A | Reiterates | 2 years ago |
Biora Therapeutics IncBIOR | 9 | Buy | $150.00 | N/A | Reiterates | 2 years ago |
Mustang Bio IncMBIO | 6 | Buy | $100.00 | N/A | Reiterates | 2 years ago |
Alpine Immune Sciences IncALPN | 7 | Buy | $50.00 | N/A | Maintains | 2 years ago |
Traws Pharma IncTRAW | 9 | Buy | $11.00 | N/A | Reiterates | 3 years ago |
Biophytis SaBPTSY | 5 | Buy | $600.00 | N/A | Reiterates | 3 years ago |
Atreca IncBCEL | 6 | Hold | N/A | N/A | Downgrades | 3 years ago |
Decibel Therapeutics IncDBTX | 6 | Hold | N/A | N/A | Downgrades | 3 years ago |
Aravive IncARAV | 10 | Hold | N/A | N/A | Downgrades | 3 years ago |
IMV IncIMVIQ | 1 | Buy | $65.00 | N/A | Reiterates | 4 years ago |
Applied Genetic Technologies CorpAGTC | 3 | Hold | N/A | N/A | Downgrades | 4 years ago |
Akouos IncAKUS | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Humanigen IncHGENQ | 3 | Hold | N/A | N/A | Downgrades | 4 years ago |
Genocea Biosciences IncGNCAQ | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Sio Gene Therapies IncSIOX | 4 | Sell | N/A | N/A | Downgrades | 4 years ago |
Sierra Oncology IncSRRA | 1 | Hold | $55.00 | N/A | Downgrades | 4 years ago |
Beyondspring IncBYSI | 4 | Hold | N/A | N/A | Downgrades | 5 years ago |
Essa Pharma IncEPIX | 3 | Buy | $32.00 | N/A | Maintains | 5 years ago |
Strata Skin Sciences IncSSKN | 2 | Buy | $30.00 | N/A | Upgrades | 6 years ago |
Principia Biopharma IncPRNB | 4 | Hold | $100.00 | N/A | Downgrades | 6 years ago |
Avid Bioservices IncCDMO | 2 | Buy | $9.00 | N/A | Reiterates | 6 years ago |
Immune Design CorpIMDZ | 1 | Buy | $7.75 | N/A | Maintains | 8 years ago |
Soligenix IncSNGX | 2 | Hold | N/A | N/A | Downgrades | 9 years ago |
Tg Therapeutics IncTGTX | 2 | Buy | $33.00 | N/A | Assumes | 9 years ago |
Palvella Therapeutics IncPVLA | 1 | Strong Buy | $720.00 | N/A | Initiates Coverage On | 9 years ago |
Verastem IncVSTM | 1 | Buy | $78.00 | N/A | Reiterates | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.